Plus Therapeutics Announces Summary of FDA Meeting on Company's cGMP Manufacturing Process for Lead Drug Candidate
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Source: apnews.com
Stay updated with breaking news from March Hedrick. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Funding from the Cancer Prevention and Research Institute of Texas (CPRIT), the second largest global public funder of cancer research, will support the...
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
AUSTIN, Texas, Aug. 15, 2022 -- Plus Therapeutics, Inc. , a clinical-stage pharmaceutical company developing innovative, targeted radiotherapeutics for rare and difficult-to-treat cancers, today... | August 15, 2022